中国中免获Barclays PLC增持177.88万股

Group 1 - The core point of the article is that Barclays PLC has increased its stake in China National Pharmaceutical Group (China National Medicine) by purchasing 1.7788 million shares at an average price of HKD 77.7508 per share, totaling approximately HKD 138 million [1] - Following this transaction, Barclays PLC's total holdings in China National Medicine have risen to 6,467,742 shares, increasing its ownership percentage from 4.33% to 5.56% [1]